XEDAR Activates the Non-Canonical NF-κB Pathway

    Kelly Verhelst, Sandra Gardam, Alice Borghi, Marja Kreike, Isabelle Carpentier, Rudi Beyaert
    Image of study
    TLDR XEDAR triggers a specific signaling pathway in cells.
    The 2015 study by Verhelst et al. found that the X-linked ectodermal dysplasia receptor (XEDAR) activates the non-canonical NF-κB signaling pathway, which involves the conversion of p100 to p52 and the subsequent movement of p52 and RelB into the nucleus. The activation of this pathway by XEDAR requires the interaction with TRAF3 and TRAF6, as well as the kinase activities of NIK and IKKα. Mutations in XEDAR's TRAF binding sites significantly reduced its ability to activate this signaling pathway. The study also identified that NIK accumulation is induced by XEDAR and that p100 processing is negatively regulated by TRAF3, CIAP1, and A20. These findings enhance the understanding of XEDAR's role in the molecular mechanisms governing non-canonical NF-κB signaling.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 488 results

    Related Research

    1 / 1 results